PDCD1 and colorectal carcinoma: Based on the successes of pectin (that we applied in the newly diagnosed CRC patients) in enhancing the efficacy of anti-PD-1 mAb, we hypothesized that pectin supplement could be purposed for immunotherapy, since a majority of patients would develop refractory resistance, despite they respond well to anti-PD-1 mAb at first.